Lakeland Industries Inc. (LAKE) carries a Roarable Rating of D- (Sell) with 38/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.
As of 2026-11-01, Lakeland Industries Inc. (NASDAQ: LAKE) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 38/100 at a spot price of $8.88 (-1.11% 1D, market cap $88.2M). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 8/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, LAKE ranks #719 in composite RQD confidence.
Within the Health Care sector (Industrial Specialties), LAKE carries a Roarable D- (38/100 RQD), trailing P/E of N/A, gross margin of 32.9%, and ROIC of -9.5%. By comparison, CNXU (Conexeu Sciences Inc.) holds a D+ grade (56/100 RQD, P/E N/A, ROIC —, cap $85.8M) and NTRB (Nutriband Inc.) posts a D- grade (40/100 RQD, P/E N/A, ROIC -35.0%, cap $80.7M). Among the 5-stock peer group, APT leads on earnings multiple (16.2x) while APT leads on capital efficiency (6.7% ROIC).
Per LAKE's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-01-31, CIK 0000798081), Lakeland Industries Inc. generated $192.6M in revenue (+15.2% YoY), -$25.3M in net income, and -$16.4M in free cash flow against $209.9M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer
Altman Z-Score 2.04 (WATCH ZONE (1.8–3.0)) • Piotroski F-Score 4/9
FRED Regime × Technicals: 18% of 52W Range • RSI-14 at 36 (NEUTRAL RANGE)
Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment
While LAKE currently carries a cautious 38/100 (D-) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.
Established market leader in Health Care with deep daily trading liquidity.
Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($10.37) and Max Pain ($9.32) forces dealer call-delta covering toward $17.76.
Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.
Lakeland Industries Inc. (LAKE) slipped -1.11% to $8.88, trading at 18% of its 52-week range ($7.15 – $16.91). Stretched risk/reward at current multiples (-10% return on capital) under elevated 10-year interest-rate pressure.
Award Expands Lakeland’s Existing Relationship with Cleveland Fire Brigade that Includes Jolly Structural Firefighting Footwear HUNTSVILLE, Ala., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Lakeland Industries, Inc. ("Lakeland Fir
Lakeland Industries, Inc. ("Lakeland Fire + Safety" or "Lakeland") (NASDAQ: LAKE), a leading global manufacturer of protective clothing and apparel for industry, healthcare and first responders, today
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +15.2% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on LAKE today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for LAKE. Explore sector supply chains on /butterfly.
Across 1016 tracked Health Care securities in the Roarable RQD universe, Lakeland Industries Inc. (LAKE) ranks #719 by composite RQD confidence (38/100, grade D-) and #678 by equity capitalization ($88.2M). Within this direct 5-issuer industry benchmark cohort, APT leads on earnings valuation at 16.2x trailing P/E, while APT leads on capital efficiency and profitability with 6.7% ROIC and 38.1% gross margin. APT currently holds the highest overall quantitative score in the immediate peer group at 58/100 (D+) compared with LAKE at 38/100 (D-).
| Ticker / Company | Roarable Grade | RQD Score | Trailing P/E | Gross Margin | ROIC | 1D Change | Market Cap | Head-to-Head |
|---|---|---|---|---|---|---|---|---|
| LAKE
ACTIVE
Lakeland Industries Inc. | D- | 38/100 | — | 32.9% | -9.5% | -1.11% | $88.2M | Benchmark Subject |
| CNXU Conexeu Sciences Inc. | D+ | 56/100 | — | — | — | -1.74% | $85.8M | /cnxu-vs-lake → |
| NTRB Nutriband Inc. | D- | 40/100 | — | 27.8% | -35.0% | +3.75% | $80.7M | /ntrb-vs-lake → |
| AGPU Axe Compute Inc. | D- | 37/100 | — | — | -35.0% | -2.01% | $101.7M | /agpu-vs-lake → |
| APT Alpha Pro Tech Ltd. | D+ | 58/100 | 16.2x | 38.1% | 6.7% | +1.28% | $56.6M | /apt-vs-lake → |
In its most recent audited fiscal period (FY2025, filed 2026-01-31), Lakeland Industries Inc. (LAKE) reported GAAP revenue of $192.6M (+15.2% vs. FY2024 revenue of $167.2M , and +54.5% cumulative change since FY2023) , GAAP net income of -$25.3M, operating cash flow of -$15.8M, and free cash flow of -$16.4M (+5.7% YoY). On the balance sheet, LAKE closed FY2025 with $209.9M in total assets against $0 in total debt (Altman Z-Score: 2.04, Piotroski F-Score: 4/9).
| Fiscal Period | Filing Date | Revenue | Net Income | Operating Cash Flow | Free Cash Flow | Total Assets | Total Debt |
|---|---|---|---|---|---|---|---|
| FY2025 (FY) | 2026-01-31 | $192.6M | -$25.3M | -$15.8M | -$16.4M | $209.9M | — |
| FY2024 (FY) | 2025-01-31 | $167.2M | -$18.1M | -$15.9M | -$17.4M | $212.5M | — |
| FY2023 (FY) | 2024-01-31 | $124.7M | $5.4M | $10.9M | $10.9M | — | — |
As of 2026-11-01, Lakeland Industries Inc. (NASDAQ: LAKE) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 38/100 at a spot price of $8.88 (-1.11% 1D, market cap $88.2M). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 8/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 3/20. Across 1016 tracked Health Care issuers, LAKE ranks #719 in composite RQD confidence.
Within the Health Care sector (Industrial Specialties), LAKE carries a Roarable D- (38/100 RQD), trailing P/E of N/A, gross margin of 32.9%, and ROIC of -9.5%. By comparison, CNXU (Conexeu Sciences Inc.) holds a D+ grade (56/100 RQD, P/E N/A, ROIC —, cap $85.8M) and NTRB (Nutriband Inc.) posts a D- grade (40/100 RQD, P/E N/A, ROIC -35.0%, cap $80.7M). Among the 5-stock peer group, APT leads on earnings multiple (16.2x) while APT leads on capital efficiency (6.7% ROIC).
Per LAKE's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-01-31, CIK 0000798081), Lakeland Industries Inc. generated $192.6M in revenue (+15.2% YoY), -$25.3M in net income, and -$16.4M in free cash flow against $209.9M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.
LAKE last traded at $8.88 (-1.11% on volume of 77,583 shares), positioning the stock -14.37% below its 50-day simple moving average ($10.37) and -12.43% below its 200-day simple moving average ($10.14). Across its 52-week range of $7.15 to $16.91, LAKE sits at the 17.7% percentile with a 14-day RSI of 36.0 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($7.77 to $9.99).
Why LAKE Stock slipped -1.11% Today — RQD Quant Desk Flash. Stretched risk/reward at current multiples (-10% return on capital) under elevated 10-year interest-rate pressure.
To protect compute speed and zero-delay Cboe BZX data quality for active members, our current $9.95/month Roarable Pro cohort is 100% full. Join the priority waiting list below and we will notify you the moment the next batch of Pro accounts opens (and lock in your $9.95/mo rate).
Link your personal ChatGPT, Claude Desktop, or Cursor via Roarable's Model Context Protocol (`mcp.roarable.com`) to query all 5,289 stocks, inspect Butterfly supply chains, and trade your `$100K Arena` account.
Interrogate SEC 10-K/10-Q filings on demand and ask custom ticker, valuation, or short-thesis questions directly to any of our 8 specialized AI Quant Analysts.
Command our AI agents to sort and sift 5,289 stocks by custom formulas, follow multi-indicator technical & cash-flow setups, and send you instant Email/SMS breakout & downgrade alerts.
Unlock sub-second Cboe BZX streaming quotes, pre-market/after-hours delta scanners, instant SEC Form 4 insider cluster alerts, and unlimited portfolio stress-testing.
All 8 Roarable Analysts (Mara Quenwick, Devon Kess, Gideon Vane, Eliott Vance, Sorel Thorne, Corin Hale, Tessa Rane, and Felix Orven) are proprietary AI Quant Analysts and automated algorithmic specialists — not human financial advisors, fiduciaries, or registered broker-dealers. While one-to-many daily stock ratings and briefings are free, custom 1-on-1 Q&A, custom AI sifting/indicator alert agents, and personal ChatGPT/Claude MCP connections consume dedicated per-user compute and require a $9.95/month Roarable Pro membership. All AI outputs are for educational and research purposes only and never constitute individualized investment advice.
Enter your Google email below for instant 1-step account activation, daily A–E stock rating alerts, and immediate access to your $100,000.00 Paper Trading Arena account.